Erlotinib in the treatment of advanced pancreatic cancer

Por Kelley, Robin K, Ko, Andrew H
Publicado em 2008

KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic

Por Wang, Grace, Kelley, Robin K., GAPPNet
Publicado em 2010

Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

Por Kelley, Robin K., Venook, Alan P.
Publicado em 2011

Biomarker Use in Colorectal Cancer Therapy

Por Kelley, Robin K., Wang, Grace, Venook, Alan P.
Publicado em 2011

Cases of Spontaneous Tumor Regression in Hepatobiliary Cancers: Implications for Immunotherapy?

Por Parks, Anna L., McWhirter, Ryan M., Evason, Kimberley, Kelley, Robin K.
Publicado no J Gastrointest Cancer (2015)

Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer

Por Kelley, Robin K., Van Bebber, Stephanie L., Phillips, Kathryn A., Venook, Alan P.
Publicado em 2011

Genomic Sequencing: Assessing The Health Care System, Policy, And Big-Data Implications

Por Phillips, Kathryn A., Trosman, Julia, Kelley, Robin K., Pletcher, Mark J., Douglas, Michael P., Weldon, Christine B.
Publicado em 2014

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls

Por Kelley, Robin K, Magbanua, Mark Jesus M, Butler, Timothy M, Collisson, Eric A, Hwang, Jimmy, Sidiropoulos, Nikoletta, Evason, Kimberley, McWhirter, Ryan M, Hameed, Bilal, Wayne, Elizabeth M, Yao, Francis Y, Venook, Alan P, Park, John W
Publicado no BMC Cancer (2015)

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanc...

Por Bendell, Johanna C., Kelley, Robin K., Shih, Kent C., Grabowsky, Jennifer A., Bergsland, Emily, Jones, Suzanne, Martin, Thomas, Infante, Jeffrey R., Mischel, Paul S., Matsutani, Tomoo, Xu, Shuichan, Wong, Lilly, Liu, Yong, Wu, Xiaoling, Mortensen, Deborah S., Chopra, Rajesh, Hege, Kristen, Munster, Pamela N.
Publicado no Cancer (2015)

Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model

Por Song, Eun-Kee, Tai, WM, Messersmith, Wells A., Bagby, Stacey, Purkey, Alicia, Quackenbush, Kevin S., Pitts, Todd M., Wang, Guoliang, Blatchford, Patrick, Yahn, Rachel, Kaplan, Jeffrey, Tan, Aik Choon, Atreya, Chloe E., Eckhardt, Gail, Kelley, Robin K., Venook, Alan, Kwak, Eunice L, Ryan, David, Arcaroli, John J.
Publicado no Int J Cancer (2014)

Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas

Por Zill, Oliver A., Greene, Claire, Sebisanovic, Dragan, Siew, LaiMun, Leng, Jim, Vu, Mary, Hendifar, Andrew E., Wang, Zhen, Atreya, Chloe E., Kelley, Robin K., Van Loon, Katherine, Ko, Andrew H., Tempero, Margaret A., Bivona, Trever G., Munster, Pamela N., Talasaz, AmirAli, Collisson, Eric A.
Publicado no Cancer Discov (2015)

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

Por Abou-Alfa, Ghassan K., Andersen, Jesper B., Chapman, William, Choti, Michael, Forbes, Stuart J., Gores, Gregory J., Hong, Theodore S., Harding, James J., Vander Heiden, Matthew G., Javle, Milind, Kelley, Robin K., Kwong, Lawrence N., Lowery, Maeve, Merrell, Allyson, Miyabe, Katsuyuki, Rhim, Andrew, Saha, Supriya, Sia, Daniela, Tanasanvimon, Suebpong, Venook, Alan, Valle, Juan W., Walesky, Chad, Whetstine, Jonathan, Willenbring, Holger, Zhu, Andrew X., Mayer, Donna, Stanger, Ben Z.
Publicado no J Gastrointest Oncol (2016)